Mark L. Gonzalgo, M.D., Ph.D.
Publication Details
-
Molecular pathways to prostate cancer.
J Urol. 2003; (6 Pt 1): 2444-52
Prostate cancer continues to be a prevalent disease in the United States and western countries. Advances in the fields of molecular biology and genetics coupled with new developments in biotechnology have increased our understanding of events associated with the initiation and progression of prostate cancer. We reviewed recent scientific discoveries relating to genetic predisposition, somatic alterations and epigenetic phenomena involved in the pathogenesis of prostate cancer.
Help
Trial Administration